sarsasapogenin has been researched along with trinitrobenzenesulfonic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, HS; Jeong, JJ; Kang, GD; Kim, DH; Kim, KA; Lim, SM | 1 |
| Mandlik, DS; Mandlik, SK; Patel, S | 1 |
2 other study(ies) available for sarsasapogenin and trinitrobenzenesulfonic acid
| Article | Year |
|---|---|
Timosaponin AIII and its metabolite sarsasapogenin ameliorate colitis in mice by inhibiting NF-κB and MAPK activation and restoring Th17/Treg cell balance.
Topics: Animals; Anti-Inflammatory Agents; Cell Differentiation; Cells, Cultured; Colitis; Colon; Lipopolysaccharides; Macrophages, Peritoneal; Male; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; NF-kappa B; Peroxidase; Saponins; Spirostans; Steroids; T-Lymphocytes, Regulatory; Th17 Cells; Trinitrobenzenesulfonic Acid | 2015 |
Protective effect of sarsasapogenin in TNBS induced ulcerative colitis in rats associated with downregulation of pro-inflammatory mediators and oxidative stress.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Colitis, Ulcerative; Cytoprotection; Down-Regulation; Drugs, Chinese Herbal; Inflammation Mediators; Male; Oxidative Stress; Rats; Rats, Wistar; Spirostans; Trinitrobenzenesulfonic Acid | 2021 |